Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1-nd |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Nesvacumab Biosimilar - Anti-ANGPT2 mAb - Research Grade |
|---|---|
| Source | CAS 1296818-77-3 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Nesvacumab,REGN-910,ANGPT2,anti-ANGPT2 |
| Reference | PX-TA1311 |
| Note | For research use only. Not suitable for human use. |
| Isotype | IgG1-nd |
| Clonality | Monoclonal Antibody |
Nesvacumab is investigated for the treatment of Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME).
Immobilized Human ANGPT2-Ang2 recombinant protein (cat. No. PX-P6245) at 0.5µg/mL (100µL/well) can bind Nesvacumab Biosimilar - Anti-ANGPT2 mAb (cat. No. PX-TA1311) in indirect ELISA with Goat Anti-human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 16.93M.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.